[Hyperbaric oxygen therapy in the treatment of benign intracranial hypertension. Follow-up of a preliminary study]. | Canada Hyperbarics Skip to main content
Clinical Study Minerva anestesiologica 1992

[Hyperbaric oxygen therapy in the treatment of benign intracranial hypertension. Follow-up of a preliminary study].

Luongo C, Mignini R, Vicario C, Sammartino A — Minerva anestesiologica, 1992

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers investigated the preliminary experience of hyperbaric oxygen therapy (HBO) in 8 out of 53 patients with benign intracranial hypertension (BIH), administering 100% oxygen at 2 atmospheres absolute daily for 15 days.

What They Found

In all 8 patients treated with hyperbaric oxygen, a gradual disappearance of signs and symptoms of elevated intracranial pressure was observed during the 15-day treatment period. However, no lasting effects of the treatment were seen after the therapy concluded.

Canadian Relevance

This study has no direct Canadian connection or specific relevance to the Canadian healthcare system.

Study Limitations

Key limitations include the very small sample size of only 8 patients receiving hyperbaric oxygen therapy and the observation of no lasting effects after treatment concluded.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 1620473
Year Published 1992
Journal Minerva anestesiologica
MeSH Terms Female; Follow-Up Studies; Humans; Hyperbaric Oxygenation; Male; Pseudotumor Cerebri

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.